Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Clinical Features, Diagnosis, and Prognosis of 22 Cases of Neurolymphomatosis : A Single-Institution Experience over 12 Years

Kentaro Narita, MD, Toshiki Terao, MD, Takafumi Tsushima, MD, Akihiro Kitadate, MD PhD, Daisuke Miura, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2019) 134 (Supplement_1): 1630.

https://doi.org/10.1182/blood-2019-126706

Published: 2019

Journal Articles

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma; The Tier Trial

Blood (2019) 134 (Supplement_1): 2879.

https://doi.org/10.1182/blood-2019-122830

Published: 2019

Journal Articles

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Blood (2017) 130 (Supplement 1): 1573.

https://doi.org/10.1182/blood.V130.Suppl_1.1573.1573

Published: 2017

Journal Articles

Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years

Yoshiaki Abe, MD, Yoshiaki Usui, MD, Kentaro Narita, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 3042.

https://doi.org/10.1182/blood.V128.22.3042.3042

Published: 2016

Journal Articles

Prognostic Significance Of Parameters Of Dynamic Contrast-Enhanced MRI Detecting Increased Bone Marrow Microcirculation In Monoclonal Plasma Cell Disorders

Jens Hillengass, MD, Judith Ritsch, Maximilian Merz, MD, Hartmut Goldschmidt, MD, Christina Kunz, PhD, Barbara Wagner-Gund, Anthony Ho, MD, Thomas M. Moehler, MD, Stefan Delorme, MD

Blood (2013) 122 (21): 3146.

https://doi.org/10.1182/blood.V122.21.3146.3146

Published: 2013

Journal Articles

Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models

Christopher W Schaefer, M.S., Deepika Lal, M.S., R Robert Vethanayagam, PhD, Joseph A Spernyak, PhD, Mukund Seshadri, PhD, Eunice S. Wang, MD

Blood (2011) 118 (21): 4293.

https://doi.org/10.1182/blood.V118.21.4293.4293

Published: 2011

Journal Articles

Prognostic Significance of the Number of Focal Lesions in Whole Body Magnetic Resonance Imaging Before and After Autologous Stem Cell Transplantation

Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc André Weber, Thomas Hielscher, Hans-Ulrich Kauczor, Stefan Delorme, Anthony D. Ho, Hartmut Goldschmidt, Kai Neben, MD

Blood (2011) 118 (21): 1812.

https://doi.org/10.1182/blood.V118.21.1812.1812

Published: 2011

Journal Articles

Correlation of Serological and MRI-Based Treatment Response to Systemic Chemotherapy In 100 Patients with Multiple Myeloma

Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Gerlinde Egerer, Hans-Ulrich Kauczor, Stefan Delorme, Anthony D. Ho, MD, FRCPC, Hartmut Goldschmidt, Kai Neben

Blood (2010) 116 (21): 2977.

https://doi.org/10.1182/blood.V116.21.2977.2977

Published: 2010

Journal Articles

Targeting Tissue Factor to Tumor Vessels. Experimental Results and First-in-Man Experience.

Wolfgang E Berdel, MD, Torsten Kessler, MD, Christian Schwöppe, PhD, Ruediger Liersch, MD, Torsten Persigehl, MD, Christoph Bremer, MD, Christoph Schliemann, MD, Rolf Mesters, MD

Blood (2009) 114 (22): 469.

https://doi.org/10.1182/blood.V114.22.469.469

Published: 2009

Journal Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

Jens Hillengass, Christian M Zechmann, Tobias Bäuerle, Christiane Heiss, Axel Benner, Kai Neben, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Stefan Delorme, Thomas M. Moehler

Blood (2008) 112 (11): 2704.

https://doi.org/10.1182/blood.V112.11.2704.2704

Published: 2008

Journal Articles

Penetration of Yttrium-90-Labeled Ibritumomab Tiuxetan (Zevalin™) into Primary CNS Lymphoma.

Philipp Kiewe, MD, Agnieszka Korfel, MD, Sofiane Maza, MD, Kristoph Jahnke, MD, Dieter L. Munz, MD, Eckhard Thiel, MD

Blood (2006) 108 (11): 2724.

https://doi.org/10.1182/blood.V108.11.2724.2724

Published: 2006

Journal Articles

Dynamic Contrast-Enhanced MRI Identifies a Distinct Group of Asymptomatic Myeloma Patients with Increased Bone Marrow Microcirculation.

Jens Hillengass, MD, Christian Zechmann, MD, Andreas Nadler, Stefan Delorme, MD, Axel Benner, Christiane Heiss, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Thomas Moehler, MD

Blood (2006) 108 (11): 5079.

https://doi.org/10.1182/blood.V108.11.5079.5079

Published: 2006

Journal Articles

The Role of Whole-Body Magnetic Resonance Imaging in the Staging and Follow-Up of Bone Disease in Multiple Myeloma.

M. Varettoni, MD, F. Calliada, MD, P. Zappasodi, MD, P. Arcuti, MD, S. Mangiacavalli, MD, C. Rusconi, MD, G. M. Pica, MD, M. Lazzarino, MD, A. Corso, MD

Blood (2005) 106 (11): 5063.

https://doi.org/10.1182/blood.V106.11.5063.5063

Published: 2005

NARROW

Clinical Features, Diagnosis, and Prognosis of 22 Cases of Neurolymphomatosis : A Single-Institution Experience over 12 Years

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma; The Tier Trial

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years

Prognostic Significance Of Parameters Of Dynamic Contrast-Enhanced MRI Detecting Increased Bone Marrow Microcirculation In Monoclonal Plasma Cell Disorders

Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models

Prognostic Significance of the Number of Focal Lesions in Whole Body Magnetic Resonance Imaging Before and After Autologous Stem Cell Transplantation

Correlation of Serological and MRI-Based Treatment Response to Systemic Chemotherapy In 100 Patients with Multiple Myeloma

Targeting Tissue Factor to Tumor Vessels. Experimental Results and First-in-Man Experience.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

Penetration of Yttrium-90-Labeled Ibritumomab Tiuxetan (Zevalin™) into Primary CNS Lymphoma.

Dynamic Contrast-Enhanced MRI Identifies a Distinct Group of Asymptomatic Myeloma Patients with Increased Bone Marrow Microcirculation.

The Role of Whole-Body Magnetic Resonance Imaging in the Staging and Follow-Up of Bone Disease in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only